Pulmonary toxicity of drugs used to treat systemic autoimmune diseases Journal Article


Authors: Libby, D.; White, D. A.
Article Title: Pulmonary toxicity of drugs used to treat systemic autoimmune diseases
Abstract: A number of drugs used to treat systemic autoimmune diseases can cause respiratory complications. These include bronchospasm, noncardiac pulmonary edema, interstitial pneumonitis and fibrosis, hypersensitivity, and numerous other disorders. Additionally, some of these drugs increase the risk of infections, particularly with opportunistic organisms. This article reviews the clinical presentation and mechanism of toxicity of drug related pulmonary complications.
Keywords: bronchoalveolar lavage; rheumatoid-arthritis; bronchiolitis obliterans; low-dose methotrexate; respiratory-distress-syndrome; pneumocystis-carinii pneumonia; connective-tissue disease; lupus-erythematosus; induced goodpastures-syndrome; d-penicillamine
Journal Title: Clinics in Chest Medicine
Volume: 19
Issue: 4
ISSN: 0272-5231
Publisher: Elsevier Inc.  
Date Published: 1998-12-01
Start Page: 809
End Page: 821
Language: English
ACCESSION: WOS:000077926200016
DOI: 10.1016/s0272-5231(05)70118-0
PROVIDER: wos
PUBMED: 9917966
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dorothy A White
    74 White